![A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity | Fierce Pharma A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity | Fierce Pharma](https://qtxasset.com/quartz/qcloud5/media/image/fiercepharma/1635953641/LarsFruegaardJorgensen.jpg/LarsFruegaardJorgensen.jpg?VersionId=X.ylOOiQkLD9N9SKVjiCKX6aeTvvx7EH)
A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity | Fierce Pharma
Erik Hageman (far right) is one of Denmark's longest-living people with type 1 diabetes, pictured here with his son Lars, who a
![Lars Rebien Sørensen to step down as head of Novo Nordisk - The Copenhagen Post – The Copenhagen Post Lars Rebien Sørensen to step down as head of Novo Nordisk - The Copenhagen Post – The Copenhagen Post](https://cphpost.dk/wp-content/uploads/2016/09/Lars-Rebien-Soerensen-3-NovoNordisk-President-CEO-lowres.png)